It is a healthcare private limited company based in Pitampura, Delhi, India, established in 2010.
2010 | Pitampura, Delhi, India | ActivePathmax Laboratories Private Limited, a active private limited company, was established on 19 February 2010 in Pitampura, Delhi, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U85100DL2010PTC199290. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.16 M.
It upholds a compliant status. Its leadership includes Sanjay Kumar (Additional Director), Manisha Khurana (Director). Past directors included Binayak Prasad, Naveen Nishchal, Roop Mohan Arora. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 231, Vidya Vihar, West Enclave, Pitampura, Delhi, 110034.
U85100DL2010PTC199290
199290
19 February 2010
₹0.50 M
₹0.16 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Pathmax Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Kumar | Additional Director | 22 Apr 2019 | Current |
| Manisha Khurana | Director | 19 Feb 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Aug 2010 | Past |
| Pramod Abcsdd | Director | 27 Sep 2013 | Past |
| Pramod Abcsdd | Director | 22 Apr 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pathmax Laboratories Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Pathmax Laboratories had a promoter holding of 64.05% and a public holding of 35.95%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Pathmax Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pathmax Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pathmax Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Pathmax Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Pathmax Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Sanjay Kumar was appointed as a Additional Director was appointed as a Additional Director on 22 Apr 2019 & has been associated with this company since 6 years 7 months . was documented.
Manisha Khurana was appointed as a Director was appointed as a Director on 19 Feb 2010 & has been associated with this company since 15 years 9 months . was recorded as a recent event.
Progress on Pathmax Laboratories Private Limited was registered on 19 Feb 2010 with Roc Delhi & aged 15 years 9 months as per MCA records. was documented.
The CIN of Pathmax Laboratories Private Limited is U85100DL2010PTC199290.
Pathmax Laboratories Private Limited is headquartered at 231, Vidya Vihar, West Enclave, Pitampura, Delhi, 110034.
Pathmax Laboratories Private Limited was incorporated on 19 February 2010.
The current directors of Pathmax Laboratories Private Limited are
The primary industry of Pathmax Laboratories Private Limited is Hospital And Medical Care.
Pathmax Laboratories Private Limited is unlisted.
The authorized capital of Pathmax Laboratories Private Limited is ₹0.50 M, and the paid-up capital is ₹0.16 M.
The compliance status of Pathmax Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX